Oncolytic virotherapy, Nature Biotechnology, vol.311, issue.7, pp.658-670, 2012. ,
DOI : 10.1038/nbt.2287
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888062
Global measles elimination, Nature Reviews Microbiology, vol.30, issue.12, pp.900-908, 2006. ,
DOI : 10.1038/nrmicro1550
Genetic Characterization of Measles Vaccine Strains, Journal of Infectious Diseases, vol.204, issue.Supplement 1, pp.533-548, 2011. ,
DOI : 10.1093/infdis/jir097
CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus, 2001. ,
Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus, J Clin Cell Immunol, vol.6, pp.291-301, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01148993
SLAM (CDw150) is a cellular receptor for measles virus, Nature, vol.406, pp.893-897, 2000. ,
REGRESSION OF BURKITT'S LYMPHOMA IN ASSOCIATION WITH MEASLES INFECTION, The Lancet, vol.298, issue.7715, pp.105-106, 1971. ,
DOI : 10.1016/S0140-6736(71)92086-1
Possible effect of measles on leukaemia, Lancet, vol.1, p.136, 1971. ,
HODGKIN'S DISEASE: REMISSIONS AFTER MEASLES, The Lancet, vol.297, issue.7699, p.593, 1971. ,
DOI : 10.1016/S0140-6736(71)91186-X
Spontaneous remission in Burkitt's lymphoma. Natl Cancer Inst Monogr, pp.61-65, 1976. ,
Measles virotherapy in a mouse model of adult T-cell leukaemia/lymphoma, Journal of General Virology, vol.92, issue.6, pp.1458-1466, 2011. ,
DOI : 10.1099/vir.0.028910-0
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice, Blood, vol.97, issue.12, pp.3746-3754, 2001. ,
DOI : 10.1182/blood.V97.12.3746
Systemic therapy of myeloma xenografts by an attenuated measles virus, Blood, vol.98, issue.7, pp.2002-2007, 2001. ,
DOI : 10.1182/blood.V98.7.2002
Innate Immune Defense Defines Susceptibility of Sarcoma Cells to Measles Vaccine Virus-Based Oncolysis, Journal of Virology, vol.87, issue.6, pp.3484-3501, 2013. ,
DOI : 10.1128/JVI.02106-12
)-Mediated Radiovirotherapy for Pancreatic Cancer, American Journal of Roentgenology, vol.195, issue.2, pp.341-349, 2010. ,
DOI : 10.2214/AJR.09.3672
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117397
Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme, Cancer Res, vol.63, pp.2462-2469, 2003. ,
Oncolytic measles virus strains have significant antitumor activity against glioma stem cells, Gene Therapy, vol.480, issue.4, pp.444-449, 2013. ,
DOI : 10.1038/mt.2009.218
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509233
Intraperitoneal therapy of ovarian cancer using an engineered measles virus, Cancer Res, vol.62, pp.4656-4662, 2002. ,
Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model, Breast Cancer Research and Treatment, vol.27, issue.4, pp.745-754, 2010. ,
DOI : 10.1007/s10549-009-0602-z
Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment, Gene Therapy, vol.27, issue.3, pp.338-347, 2013. ,
DOI : 10.1007/s00259-008-1022-8
A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer, Breast Cancer Research and Treatment, vol.7, issue.8, pp.177-184, 2006. ,
DOI : 10.1007/s10549-006-9200-5
Measles virus causes immunogenic cell death in human melanoma, Gene Therapy, vol.14, issue.1, pp.7-15, 2013. ,
DOI : 10.1038/sj.gt.3302609
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378495
Enhanced Antitumor Effects of an Engineered Measles Virus Edmonston Strain Expressing the Wild-type N , P , L Genes on Human Renal Cell Carcinoma, Molecular Therapy, vol.18, issue.3, pp.544-551, 2010. ,
DOI : 10.1038/mt.2009.296
Oncolytic measles viruses encoding interferon ?? and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy, Cancer Gene Therapy, vol.60, issue.8, pp.550-558, 2010. ,
DOI : 10.1038/sj.gt.3301787
Measles Virus Induces Oncolysis of Mesothelioma Cells and Allows Dendritic Cells to Cross-Prime Tumor-Specific CD8 Response, Cancer Research, vol.68, issue.12, pp.4882-4892, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-6265
URL : https://hal.archives-ouvertes.fr/pasteur-00330770
Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine, BMC Cancer, vol.325, issue.1, p.508, 2012. ,
DOI : 10.1016/j.bbrc.2004.09.219
Treatment of medulloblastoma with a modified measles virus, Neuro-Oncology, vol.12, issue.10, pp.1034-1042, 2010. ,
DOI : 10.1093/neuonc/noq057
Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma, BMC Cancer, vol.60, issue.6, p.427, 2012. ,
DOI : 10.1126/science.282.5392.1332
URL : http://doi.org/10.1186/1471-2407-12-427
Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas, BioMed Research International, vol.20, issue.6, p.387362, 2013. ,
DOI : 10.1158/0008-5472.CAN-04-0884
High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus, Cancer Research, vol.64, issue.14, pp.4919-4926, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-0884
The human CD46 molecule is a receptor for measles virus (Edmonston strain), Cell, vol.75, issue.2, pp.295-305, 1993. ,
DOI : 10.1016/0092-8674(93)80071-L
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus, J Virol, vol.67, pp.6025-6032, 1993. ,
Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors, Molecular Immunology, vol.40, issue.2-4, pp.109-123, 2003. ,
DOI : 10.1016/S0161-5890(03)00112-3
Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas, Journal of Oral Pathology and Medicine, vol.90, issue.9, pp.560-567, 2006. ,
DOI : 10.1002/hed.10145
Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus, PLoS Pathogens, vol.105, issue.Pt 6, p.1002240, 2011. ,
DOI : 10.1371/journal.ppat.1002240.s002
Adherens junction protein nectin-4 is the epithelial receptor for measles virus, Nature, vol.199, pp.530-533, 2011. ,
DOI : 10.1038/nature10639
An Exit Strategy for Measles Virus, Science, vol.334, issue.6063, pp.1650-1651, 2011. ,
DOI : 10.1126/science.1217378
Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum, American Journal of Clinical Pathology, vol.134, issue.5, pp.835-845, 2010. ,
DOI : 10.1309/AJCPGXK0FR4MHIHB
Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer, Cancer Research, vol.69, issue.16, pp.6694-6703, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-0016
Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme, 2005. ,
Measles Vaccine Strains for Virotherapy of Non???Small-Cell Lung Carcinoma, Journal of Thoracic Oncology, vol.9, issue.8, pp.1101-1110, 2014. ,
DOI : 10.1097/JTO.0000000000000214
Primary resistance phenomena to oncolytic measles vaccine viruses, Int J Oncol, vol.43, pp.103-112, 2013. ,
Regulation of type I interferon responses, Nature Reviews Immunology, vol.7, issue.1, pp.36-49, 2014. ,
DOI : 10.1038/nri3581
An evolutionary perspective on the broad antiviral specificity of MxA, Current Opinion in Microbiology, vol.16, issue.4, pp.493-499, 2013. ,
DOI : 10.1016/j.mib.2013.04.005
Deregulation of Interferon Signaling in Malignant Cells, Pharmaceuticals, vol.3, issue.2, pp.406-418, 2010. ,
DOI : 10.3390/ph3020406
p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs, Proceedings of the National Academy of Sciences, vol.110, issue.1, pp.89-98 ,
DOI : 10.1073/pnas.1216922110
Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus, J Clin Cell Immunol, vol.6, pp.291-301, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01148993
Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells, Blood, vol.106, issue.7, pp.2287-2294, 2005. ,
DOI : 10.1182/blood-2004-11-4558
Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer, Cancer Research, vol.70, issue.3, pp.875-882, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-2762
Immunogenecity signals 1,2,3... and 0, Immunology Today, vol.10, issue.9, pp.283-286, 1989. ,
DOI : 10.1016/0167-5699(89)90081-9
Toll-Like Receptor Signaling Pathways, Frontiers in Immunology, vol.462, p.461, 2014. ,
DOI : 10.1038/nature08460
URL : http://doi.org/10.3389/fimmu.2014.00461
Tolerance, Danger, and the Extended Family, Annual Review of Immunology, vol.12, issue.1, pp.991-1045, 1994. ,
DOI : 10.1146/annurev.iy.12.040194.005015
Opinion: Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses, Nature Reviews Immunology, vol.29, issue.6, pp.469-478, 2004. ,
DOI : 10.1126/science.285.5430.1058
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity, Frontiers in Oncology, vol.22, issue.Pt 12, p.74, 2014. ,
DOI : 10.1038/mt.2014.34
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death, The Journal of Experimental Medicine, vol.157, issue.12, pp.1691-1701, 2005. ,
DOI : 10.1073/pnas.93.18.9730
The convergence of radiation and immunogenic cell death signaling pathways, Frontiers in Oncology, vol.2, p.88, 2012. ,
DOI : 10.3389/fonc.2012.00088
Immunogenicity of 56??C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells, The Prostate, vol.177, issue.12, pp.1343-1352, 2009. ,
DOI : 10.1002/pros.20981
High hydrostatic pressure induces immunogenic cell death in human tumor cells, International Journal of Cancer, vol.132, issue.5, pp.1165-1177, 2014. ,
DOI : 10.1002/ijc.28766
Increased expression of inducible HSP70 in apoptotic cells is correlated with their efficacy for antitumor vaccine therapy, International Journal of Cancer, vol.14, issue.4, pp.575-583, 2004. ,
DOI : 10.1002/ijc.20249
Hyperthermia Enhances CTL Cross-Priming, The Journal of Immunology, vol.176, issue.4, pp.2134-2141, 2006. ,
DOI : 10.4049/jimmunol.176.4.2134
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation, Nature, vol.157, issue.6894, pp.191-195, 2002. ,
DOI : 10.1016/S0968-0004(00)01777-1
Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments, Cell Death and Differentiation, vol.17, issue.1, pp.39-49, 2014. ,
DOI : 10.1038/cdd.2013.84
Crosstalk between ER stress and immunogenic cell death, Cytokine & Growth Factor Reviews, vol.24, issue.4, pp.311-318, 2013. ,
DOI : 10.1016/j.cytogfr.2013.05.001
Autophagy and Cellular Immune Responses, Immunity, vol.39, issue.2, pp.211-227, 2013. ,
DOI : 10.1016/j.immuni.2013.07.017
URL : http://doi.org/10.1016/j.immuni.2013.07.017
Mechanisms and Functions of Inflammasomes, Cell, vol.157, issue.5, pp.1013-1022, 2014. ,
DOI : 10.1016/j.cell.2014.04.007
Poly IC Triggers a Cathepsin D- and IPS-1-Dependent Pathway to Enhance Cytokine Production and Mediate Dendritic Cell Necroptosis, Immunity, vol.38, issue.4, pp.717-728, 2013. ,
DOI : 10.1016/j.immuni.2012.12.007
URL : http://doi.org/10.1016/j.immuni.2012.12.007
Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance, Immunity, vol.38, issue.2, pp.209-223, 2013. ,
DOI : 10.1016/j.immuni.2013.02.003
F-Actin Is an Evolutionarily Conserved Damage-Associated Molecular Pattern Recognized by DNGR-1, a Receptor for Dead Cells, Immunity, vol.36, issue.4, pp.635-645, 2012. ,
DOI : 10.1016/j.immuni.2012.03.008
Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death, Cell Cycle, vol.9, issue.15, pp.3072-3077, 2010. ,
DOI : 10.4161/cc.9.15.12459
Calreticulin exposure dictates the immunogenicity of cancer cell death, Nature Medicine, vol.279, issue.1, pp.54-61, 2007. ,
DOI : 10.1038/nm1523
URL : https://hal.archives-ouvertes.fr/inserm-00451702
Heat Shock Proteins and Their Use as Anticancer Vaccines, Clinical Cancer Research, vol.10, issue.24, pp.8142-8146, 2004. ,
DOI : 10.1158/1078-0432.CCR-04-1194
Toll-like receptor 4???dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Nature Medicine, vol.289, issue.9, pp.1050-1059, 2007. ,
DOI : 10.1038/nm1622
URL : https://hal.archives-ouvertes.fr/hal-00316924
HMGB1 and RAGE in Inflammation and Cancer, Annual Review of Immunology, vol.28, issue.1, pp.367-388, 2010. ,
DOI : 10.1146/annurev.immunol.021908.132603
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance, Nature, vol.127, issue.7261, pp.282-286, 2009. ,
DOI : 10.1038/nature08296
Chemotherapy induces ATP release from tumor cells, Cell Cycle, vol.8, issue.22, pp.3723-3728, 2009. ,
DOI : 10.4161/cc.8.22.10026
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice, Science, vol.334, issue.6062, pp.1573-1577, 2011. ,
DOI : 10.1126/science.1208347
New perspectives in cancer virotherapy: bringing the immune system into play, Immunotherapy, vol.2, issue.2, pp.185-199, 2010. ,
DOI : 10.2217/imt.10.6
URL : https://hal.archives-ouvertes.fr/pasteur-00507434
Trial watch, OncoImmunology, vol.71, issue.6, p.24612, 2013. ,
DOI : 10.1038/onc.2010.500
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor???Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma, Journal of Clinical Oncology, vol.27, issue.34, pp.5763-5771, 2009. ,
DOI : 10.1200/JCO.2009.24.3675
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer, Nature Medicine, vol.53, issue.3, pp.329-336, 2013. ,
DOI : 10.1038/nm.3089
Neutrophils contribute to the measles virus-induced antitumor effect: enhancement by granulocyte macrophage colony-stimulating factor expression, Cancer Res, vol.63, pp.6463-6468, 2003. ,
Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells, OncoImmunology, vol.2, issue.5, p.24212, 2013. ,
DOI : 10.1089/jir.2011.0077
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667908
Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells, Clinical Cancer Research, vol.19, issue.5, pp.1147-1158, 2013. ,
DOI : 10.1158/1078-0432.CCR-12-2733
Potential applications for plasmacytoid dendritic cells in cancer immunotherapy, Immunotherapy, vol.4, issue.10, pp.979-982, 2012. ,
DOI : 10.2217/imt.12.115
Tumoricidal activity of human dendritic cells, Trends in Immunology, vol.35, issue.1, pp.38-46, 2014. ,
DOI : 10.1016/j.it.2013.10.007
Cellular receptors, differentiation and endocytosis requirements are key factors for type I IFN response by human epithelial, conventional and plasmacytoid dendritic infected cells by measles virus, Virus Research, vol.152, issue.1-2, pp.115-125, 2010. ,
DOI : 10.1016/j.virusres.2010.06.013
URL : https://hal.archives-ouvertes.fr/ensl-00815605
Inhibition of Toll-Like Receptor 7- and 9-Mediated Alpha/Beta Interferon Production in Human Plasmacytoid Dendritic Cells by Respiratory Syncytial Virus and Measles Virus, Journal of Virology, vol.79, issue.9, pp.5507-5515, 2005. ,
DOI : 10.1128/JVI.79.9.5507-5515.2005
Autophagy Induction by the Pathogen Receptor CD46, Cell Host & Microbe, vol.6, issue.4, pp.354-366, 2009. ,
DOI : 10.1016/j.chom.2009.09.006
URL : https://hal.archives-ouvertes.fr/pasteur-00456148
Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus, J Clin Cell Immunol, vol.6, pp.291-301, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01148993
Sustained Autophagy Contributes to Measles Virus Infectivity, PLoS Pathogens, vol.87, issue.8, p.1003599, 2013. ,
DOI : 10.1371/journal.ppat.1003599.s012
URL : https://hal.archives-ouvertes.fr/hal-00965032
Host factors and measles virus replication, Current Opinion in Virology, vol.2, issue.6, pp.773-783, 2012. ,
DOI : 10.1016/j.coviro.2012.10.008
Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways, Expert Opinion on Biological Therapy, vol.63, issue.9, pp.1163-1176, 2009. ,
DOI : 10.1073/pnas.0803988105
Inhibition of IFN-??/?? signaling by two discrete peptides within measles virus V protein that specifically bind STAT1 and STAT2, Virology, vol.383, issue.1, pp.112-120, 2009. ,
DOI : 10.1016/j.virol.2008.10.014
URL : https://hal.archives-ouvertes.fr/pasteur-00360178
Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-??/?? signaling, Virology, vol.368, issue.2, pp.351-362, 2007. ,
DOI : 10.1016/j.virol.2007.06.037
URL : https://hal.archives-ouvertes.fr/hal-00167680
The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-?? promoter, Proceedings of the National Academy of Sciences, vol.101, issue.49, pp.17264-17269, 2004. ,
DOI : 10.1073/pnas.0407639101
The C protein of measles virus inhibits the type I interferon response, Virology, vol.315, issue.2, pp.389-397, 2003. ,
DOI : 10.1016/S0042-6822(03)00537-3
Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction, Journal of General Virology, vol.85, issue.10, pp.2991-2999, 2004. ,
DOI : 10.1099/vir.0.80308-0
Mechanisms of Interferon-alpha induced apoptosis in malignant cells, Oncogene, vol.21, issue.8, pp.1251-1262, 2002. ,
DOI : 10.1038/sj.onc.1205179
Type I interferon is selectively required by dendritic cells for immune rejection of tumors, The Journal of Experimental Medicine, vol.134, issue.10, pp.1989-2003, 2011. ,
DOI : 10.4049/jimmunol.0803214
dendritic cells, The Journal of Experimental Medicine, vol.61, issue.10, pp.2005-2016, 2011. ,
DOI : 10.1158/0008-5472.CAN-07-5324
Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus, J Clin Cell Immunol, vol.6, pp.291-301, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01148993